Tag: Hormone Replacement Therapy
Menopausal Hormone Therapy Use Beyond 65 Years Beneficial
Hormone therapy use linked to risk reductions in mortality
Menopausal Hormone Therapy May Improve Depression Symptoms
Authors say more studies are needed to understand ideal timing window for treatment initiation
Prostate-Specific Antigen Levels Posttreatment May Not Predict Overall Survival
Biochemical recurrence does not meet the criteria to be a reliable surrogate endpoint for overall survival
Hormone Therapy May Up Odds of GERD in Postmenopausal Women
Significant direct association seen between estrogen use, progestogen use, combined hormone therapy with gastroesophageal reflux disease
Menopausal Hormone Therapy Positively Linked to Dementia
Higher hazard ratios noted with increasing duration of use; increased risk seen for those receiving treatment at age 55 years or younger
Risk of Hypertension Up With Use of Oral Estrogen-Only Hormone Therapy
Positive associations seen for duration of estrogen exposure, cumulative dose of estrogen with risk of hypertension
Hormone Therapy Not Linked to Lung Cancer in Postmenopausal Women
In subgroup analyses, lower risk was seen with cumulative dosage of ≥401 mg or with therapy duration of five years or longer
Systemic Hormone Therapy During Menopause May Up Risk for Depression
Initiating systemic hormone therapy before age 50 years linked to increased risk for depression
Odds of COVID-19 Mortality Lower for Women Receiving HRT
Receiving hormone replacement therapy within six months of recorded COVID-19 diagnosis linked to reduction in mortality
USPSTF Advises Against Hormone Therapy to Prevent Chronic Conditions
USPSTF recommends against hormone therapy for primary prevention of chronic conditions in postmenopausal persons
